ViewRay postponed its initial public offering with which it planned to raise $52 million for its MRI-guided radiation therapy technology, Renaissance Capital reported.
Oakwood Village, Ohio-based ViewRay had planned to float 4 million shares at $12 to $14 apiece.
Those terms, set last month, were well under the $69 million target ViewRay set in its initial IPO filing. ViewRay’s plan was to list on the NASDAQ exchange under the “VRAY” symbol.
Help employers find you! Check out all the jobs and post your resume.
